Press Releases
Early construction of prototype innovative light rail vehicle for the City of Coventry
On the 25th November Coventry City Councillor Jim O'Boyle, Coventry Cabinet Member for Jobs and Regeneration, took the opportunity to see how the construction of the Coventry VLR prototype, developed by engineers at WMG, University of Warwick for the City of Coventry is progressing.
Clinical trial to compare anaesthesia impact on recovery post-surgery
A new clinical trial will compare two types of anaesthetic to determine how soon after surgery they allow patients to return home. The Volatile vs Total intravenous Anaesthesia for major non-cardiac surgery (VITAL) trial is led by Warwick Clinical Trials Unit at the University of Warwick and will compare two methods of delivering anaesthesia to a patient: inhalation and intravenous
Warwick scientists design model to predict cellular drug targets against Covid-19
A computational model of a human lung cell has been used to understand how SARS-CoV-2 draws on human host cell metabolism to reproduce by researchers at the University of Warwick. This study helps understand how the virus uses the host to survive, and enable drug predictions for treating the virus to be made.
Migrant Leaders founder to speak on inclusion in professional world – EUTOPIA Week
The Founder and CEO of Migrant Leaders — a charity that helps disadvantaged young people from all backgrounds to access and succeed within the professional world — will be speaking to students from across Europe as part of EUTOPIA Week, hosted by the University of Warwick, her alma mater.
Diabetic drug could slow the progression of Parkinson’s disease
· A hallmark of Parkinson's disease is the degeneration of a group of neurons in the brain that release the neurotransmitter dopamine (dopaminergic neurons). By introducing low concentrations of structurally-defined aggregates of alpha synuclein, a key toxic species in Parkinson’s disease, into single dopaminergic neurons, researchers from the University of Warwick have shown these protein aggregates open a specific channel in the cell membrane, reducing neuronal excitability. Furthermore they’ve shown that this can be partially prevented by pre-application of the commonly used anti-diabetic drug, glibenclamide.
New engineering partnership to develop digital marketplace to improve manufacturing supply chain
A research team, including WMG at the University of Warwick, led by Swansea University College of Engineering, are developing a pilot online marketplace designed to optimise manufacturing supply chain networks and create a new industry-wide business model.